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Enabling Meta-Analysis in Systematic 
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Possible solutions to the problems of clinical heterogeneity of outcome measures and inad- 
equate reporting of results for randomized controlled trials (RCTs) on carpal tunnel syndrome 
(CTS) are presented. Meta-analysis was impeded by these problems in 2 systematic reviews 
concerning conservative and surgical treatment options for CTS. A solution to the problem of 
inadequate data presentation is to add explicit information on minimal requirements with 
regard to data presentation to guidelines for the reporting of studies. To resolve the problem 
of clinical heterogeneity of the outcomes there should be consensus on the (validated) 
outcomes that should be used in RCTs. For CTS there is little evidence available on the 
reliability, validity, and responsiveness to change of the commonly used outcomes in RCTs. 
Resolving both problems will increase the comparability of RCTs, enabling the calculation of 
a pooled estimate of effect in a meta-analysis. (J Hand Surg 2002;27A:828-832. Copyright © 
2002 by the American Society for Surgery of the Hand.) 
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Systematic reviews of high-quality, randomized 
controlled trials (RCTs) are considered to be the 
highest level of evidence in research concerning 
medical interventions.~ To quantify the effect of the 
various treatment options, preferably a meta-analysis 
is performed. By combining individual study results 
a precise estimate of the magnitude of the treatment 
effect can be obtained. Meta-analysis is, therefore, an 
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important part of a systematic review. Meta-analysis 
is only feasible if RCTs are clinically homogeneous, 
that is, if the patients, interventions, comparisons, 
outcomes, and timing of follow-up measurements are 
sufficiently similar. 2 Randomized controlled trials, 
however, may use a range of different outcome mea- 
sures. 3'4 Another prerequisite for combining study 
results is adequate and uniform data presentation. 
Reporting of results in biomedical journals is often 
inadequate. 5"6
This article presents possible solutions to the prob- 
lems of clinical heterogeneity of the outcome mea- 
sures and inadequate r porting of results for RCTs on 
carpal tunnel syndrome (CTS). First we show, how- 
ever, that meta-analysis was impeded by these prob- 
lems in 2 systematic reviews concerning conserva- 
tive and surgical treatment options for CTS.  7'~ 
Methods 
Systematic Reviews 
To identify publications, a search was performed 
with Medline (January 1966-March 2000), Embase 
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(January 1988-February 2000), and the Cochrane 
Controlled Trials Register (2000, issue 1), together 
with reference checking. A generic search for RCTs  9 
was combined with a specific search for CTS (by 
using the key words carpal tunnel syndrome, carpal 
tunnel, carpal syndrome, and tunnel syndrome). To 
be included, a study had to meet the following cri- 
teria: (t) the study population consisted of patients 
with CTS; (2) the efficacy of one or more conserva- 
tive treatment options was evaluated or different 
surgical techniques were compared; (3) the study 
was designed as an RCT; and (4) the results were 
published as a full report, written in Dutch, English, 
French, or German. Studies were selected by 2 re- 
viewers independently and disagreements were dis- 
cussed to reach a consensus. 
Data from the articles were extracted indepen- 
dently by 2 reviewers and recorded on a standardized 
form. Discrepancies were identified and resolved af- 
ter discussion. Information was collected on patients, 
interventions, outcomes, timing of follow-up mea- 
surements, and results. Outcome measures were con- 
sidered to be clinically homogeneous if the defini- 
tions and measurement scales were sufficiently 
similar in the opinion of the reviewers. Reporting of 
the results was considered to be adequate if any of 
the following data were presented for each treatment 
group, next to the number of patients per group: the 
mean and SD; the median and (interquartile) range of 
the outcome measure (continuous outcomes); the 
number of patients with the outcome of interest (di- 
chotomous outcomes); and the frequency distribution 
of the outcome measure (ordinal outcomes). The 
feasibility of combining individual study results was 
investigated based on both the similarity of outcome 
measures and adequacy of reporting of the results. 
Results 
Regarding the conservative treatment options there 
were 2 studies available for each of the following 
contrasts of interventions: steroid injections versus 
placebo, ~ 0,~ ~ ultrasound versus placebo, 12,~ 3pyridox- 
ine versus placebo,~4' 15 diuretics versus placebo, ~6.~ 7 
and oral steroids versus placebo. ~6.18 Of the RCTs on 
surgical techniques 7 RCTs compared endoscopic 
carpal tunnel release with open carpal tunnel release 
(OCTR),19-26 3 RCTs evaluated the effect of OCTR 
with a new incision technique versus OCTR with a 
standard incision, 27 3o and 3 RCTs compared OCTR 
with additional internal neurolysis with OCTR 
alone.31-34 
Data presentation i the RCTs concerning conser- 
vative treatment options for CTS was generally ad- 
equate. The most commonly used outcome measures 
were those related to symptoms of CTS. A wide 
variety of those measures were used including the 
following: specific descriptions of symptoms (eg, 
pain, paraesthesias), 11"~3 more general expressions 
(eg, night discomfort or just symptoms),m'14 combi- 
nations of symptoms (eg, night/day pain/paraesthe- 
sias, global symptom score), J3.~6.~8 measures relating 
to improvement of symptoms (eg, symptoms im- 
proved/changed/worsened), 15 or severity of symp- 
toms (eg, main complaints: no complaints at all [0] to 
the most intense complaints I can imagine [10]). ~2 
Because pooling of heterogeneous outcomes will 
lead to an uninterpretable and misleading pooled 
estimate, meta-analysis not feasible. Only the 2 
trials concerning the efficacy of oral steroids ~6"~8 
used the same outcome measure, but unfortunately 
only one 16 adequately reported means and SDs. Two 
of the other outcome measures (distal motor latency 
and distal sensory latency) were considered to be 
sufficiently similar, but this was only a very small 
subset of all outcomes used and in our opinion not 
the most important ones. In general, pooling of a 
subset of outcome measures may be misleading. 
The RCTs concerning surgical treatment options 
for CTS also used many different ypes of outcomes 
related to symptoms, but the other commonly used 
outcome measures (such as grip and pinch strength, 
manual muscle testing, 2-point discrimination, 
Semmes-Weinstein monofilament testing, nerve con- 
duction studies, and return to work) were considered 
to be sufficiently similar. Data presentation, how- 
ever, was often inadequate and combining individual 
study results is therefore not possible. Most articles 
reported both pre- and postoperative data but did not 
add change scores. In most cases dichotomous data 
were reported correctly. For continuous data, how- 
ever, many articles failed to report the standard e- 
viation of the Outcome 23"25'26'28'29"31 and/or the total 
number of patients in each group.  19"26'27~33"34 Some-  
times data had to be estimated from graphs, which is 
often very inaccurate because of the unclear scales 
used on the vertical axes.  23"28 3o Furthermore in 
some studies data for a particular outcome were 
presented as dichotomous data, whereas in other 
studies they were presented as continuous data or, for 
example, as percentage change from baseline. 26'~29 
Because pooling of the data was not possible in 
both systematic reviews on CTS, qualitative analyses 
were performed instead by using a rating system 
consisting of 4 levels of evidenceY 
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Enabling Meta-Analysis 
The aim of this article was to present possible 
solutions to the problems of clinical heterogeneity of 
the outcome measures and inadequate reporting of 
results for RCTs on CTS. This will increase the 
comparability of the RCTs, enabling the calculation 
of a pooled estimate of effect in a meta-analysis, in
addition to estimating the strength of the evidence in 
a qualitative analysis. Other aspects of clinical ho- 
mogeneity, that is, similarity of the patients, inter- 
ventions, comparisons, and timing of follow-up mea- 
surements are not addressed. 
Outcome Measures 
To resolve the problem of clinical heterogeneity of 
the outcome measures in a particular field of re- 
search, for example, CTS research, the outcomes and 
the instruments used to measure these outcomes 
should be standardized. In addition to this set of 
standard outcomes, researchers could add outcome 
measures of their own choice. A good example of 
efforts to standardize outcome measures i  the Out- 
come Measures in Rheumatoid Arthritis Clinical Tri- 
als project, the mission of which was to develop 
consensus on a core set of outcomes for rheumatoid 
arthritis (and other major musculoskeletal condi- 
tions). 36 Another recent example is the proposal for 
standardized use of outcome measures for low back 
pain research. 37 Also for CTS research and research 
in other fields efforts should be made to achieve 
international consensus on the use of outcomes in 
RCTs, similar to the efforts that resulted in consen- 
sus criteria for the classification of CTS in epidemi- 
ologic studies. 38 
Outcome measures elected for standardized use 
should be relevant to patient health status and should 
preferably be validated (ie, evaluated with regard to 
reliability, validity, and responsiveness to change), 
otherwise invalid outcomes might be combined, pro- 
viding a precise estimate of the wrong results. There 
is little evidence available, however, on the reliabil- 
ity, validity, and responsiveness to change of the 
commonly used outcome measures in CTS studies 
and more research is therefore needed. In 1993 a 
self-administered questionnaire for CTS was intro- 
duced, consisting of a scale for the assessment of 
severity of symptoms and a scale for the assessment 
of functional status. 39 These scales have been re- 
ported to be reproducible, internally consistent, 
valid, and responsive to clinical change 39'4° and have 
subsequently been used in several studies.  24"41'42 
Four of the 9 studies on conservative treatment op- 
tions started including patients after the publication 
of this questionnaire but unfortunately did not in- 
clude it as an outcome measure. 9'12"13a6 
Reporting of Results 
The problem of inadequate r porting of the results 
can easily be resolved. There clearly has to be a 
standardized format for the presentation of data that 
includes the key elements needed for pooling. For 
dichotomous outcomes the number of patients with 
the outcome of interest and the total number of 
patients hould be presented for each treatment group 
to enable calculation of a pooled estimate of effect 
(eg, odds ratio, risk ratio, or risk difference). For 
continuous outcomes, the mean and SD of the out- 
come measure and the total number of patients 
should be presented for each treatment group to 
enable calculation of a mean difference or a stan- 
dardized mean difference (effect size). These values 
should be presented for both follow-up data and 
change scores. Presentation of the median and (in- 
terquartile) range is appropriate for reporting if the 
outcome is not normally distributed, but methods to 
pool these data have not yet been developed. 
Many journals have already adopted guidelines for 
the reporting of studies. Since 1988 the Uniform 
Requirements for Manuscripts Submitted to Biomed- 
ical Journals includes a section on the presentation 
of statistical aspects. 43 This section is quite brief: 
"When possible, quantify findings and present hem 
with appropriate indicators of measurement error or 
uncertainty (such as confidence intervals)," Give 
numbers of observations," and "Identify statistical 
measures of variation such as standard eviation and 
standard error of the mean." In 1997 these uniform 
requirements were accepted by more than 500 jour- 
nals.44 
An important recent example is the Consolidated 
Standards of Reporting Trials (CONSORT) state- 
ment published in 1996. 45 By the end of 1997 this 
guideline was adopted by more than 70 journals. 46 In 
these guidelines the section on presentation of the 
data is rather concise: "State estimated effect of 
intervention on primary and secondary outcome 
measures, including a point estimate and measure of 
precision (confidence interval)," State results in ab- 
solute numbers when feasible (eg, 10/20 not 50%)," 
and "Present summary data and appropriate descrip- 
tive and inferential statistics in sufficient detail to 
permit alternative analyses and replication." 
Most studies included in the systematic review 
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concerning surgical treatment options for CTS were 
published before the introduction of the CONSORT 
statement. Moreover, only one of the journals in 
which these RCTs were published has endorsed 
the statement (Nederlands Tijdschrift voor Genees- 
kunde). Some of the other journals have included 
guidelines on data presentation i their instructions 
for authors, but none of them states that studies 
should be reported in accordance with the Uniform 
Requirements. 
A possible solution to the problem of inadequate 
data presentation would be to add explicit informa- 
tion to a revised CONSORT statement on minimal 
requirements with regard to data presentation i clud- 
ing the key elements needed for pooling. To over- 
come the problem of inadequate data presentation i
a systematic review, additional information could be 
requested from the researchers of the original stud- 
ies. This may not be feasible in many reviews, how- 
ever, because of a lack of time and resources. Fur- 
thermore data of trials published at least 5 years 
previously might no longer be available, or it might 
be difficult to find the researchers of old trials. 
The authors thank Dick van Geldere and Sandra Struijs for perform- 
ing the data extraction. 
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